Regional Midazolam in Quadratus Lumborum Block

• Status: Not yet recruiting
• Trial end date: 2023-01-20
• Target enrollment: 0
• Participant gender: Female

Summary

Midazolam has been used in regional anesthesia of brachial plexus block; it has offered accepted postoperative pain relief. This study will use it in as an adjuvant to bupivacaine 0.25% in quadratus lumborum block in caesarean section

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Bupivacaine; Midazolam

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) physical status I or II

• age from 24 to 40 years old

• weight from 50 to 80 kg,

• normal singleton pregnancy with a gestation of at least 37 weeks

Exclusion Criteria:

• Coagulopathy

• maternal anatomic abnormalities in the block region

• localized infection

• incapable of comprehending or using the verbal rating pain scoring system

• Included medications allergy

• history of chronic pain or regular opioid use.